CVS Health Corp.

2026-08-24 19:52; UTC

CVS Health announced a partnership with the Alex Morgan Foundation to redevelop a soccer pitch in California, with shares trading higher since Friday's close.

2026-08-21 19:56; UTC

CVS Health shares reached an 11-week low of $93.01 amid ongoing negative market sentiment, despite the company's focus on heart health disparities.

2026-08-20 19:41; UTC

CVS Health opened a temporary mobile pharmacy in Pawling, NY, after a fire destroyed its previous location and donated $5,000 to a local nonprofit.

2026-08-19 19:42; UTC

CVS Health shares are trading lower today, reflecting a broader market backdrop. The stock is significantly below its 20-day moving average.

2026-08-18 19:26; UTC

CVS Health engages in community support, investing $35 million in housing. Shares are higher amid positive investor sentiment and board changes.

2026-08-17 20:01; UTC

CVS Health Corp shares are lower amid scrutiny from Senator Elizabeth Warren over healthcare consolidation, raising investor concerns about costs and competition in the sector.

2026-08-14 20:06; UTC

CVS Health shares are rising as a study highlights growing employer reliance on pharmacy benefit managers to manage drug costs and enhance healthcare affordability.

2026-08-12 19:26; UTC

CVS shares rise after JPMorgan raises price target to $118.

2026-08-11 23:06; UTC

CVS Health Corp shares traded roughly flat in after-market hours, reflecting routine trading activity within a narrow range since Tuesday's close.

2026-08-10 20:06; UTC

CVS shares are lower as Senator Warren criticizes the company's role in healthcare consolidation and supports the Patients Before Monopolies Act.

2026-08-08 00:01; UTC

CVS Health Corp shares are lower in after-market hours, continuing a decline seen over the last four sessions amid ongoing market concerns.

2026-08-07 19:16; UTC

CVS Health shares are lower amid ongoing challenges and a recent walkout by pharmacists in Wakefield, reflecting persistent weakness in the stock.

2026-08-06 23:51; UTC

CVS Health Corp traded roughly flat during after-market hours, continuing to stay below its 20-day moving average for the fourth consecutive session.

2026-08-05 20:03; UTC

CVS Health shares are lower today after reporting second-quarter net income of $2.98 billion, amid cautious 2027 guidance raising investor concerns.

2026-08-04 19:33; UTC

CVS Health shares are declining amid broader losses in the Health Care Services sector, despite receiving multiple awards for employee development initiatives.

2026-08-03 23:46; UTC

CVS Health shares rose in after-market hours following a survey showing increased provider-payer trust scores and improved perceptions of digital tools in healthcare.

2026-07-30 20:09; UTC

CVS Health shares are declining amid broader market volatility following mixed economic signals, including lower-than-expected GDP growth and rising jobless claims.

2026-07-29 23:16; UTC

CVS Health Corp shares are modestly higher in after-market trading, having shown a steady climb throughout the session with no specific news identified.

2026-07-28 23:11; UTC

CVS Health Corp shares are lower in after-market hours amid a broader market decline. The Trump administration's end of Medicare drug plan subsidies raises cost concerns.

2026-07-27 18:07; UTC

CVS Health Corp has launched a new service for pet prescriptions, though shares are lower during Monday's session amid broader market declines.

2026-07-24 23:16; UTC

CVS Health Corp shares are trading roughly flat in after-market hours, reflecting minor fluctuations since Friday's close within a narrow range.

2026-07-23 00:02; UTC

CVS Health Corp trades higher in after-market hours, reflecting strong performance and positive momentum amid efforts to address retail theft with a new store layout.

2026-07-22 23:06; UTC

CVS Health shares are higher in after-market trading, remaining above its 20-day moving average and near the top of its one-month range.

2026-07-20 19:16; UTC

CVS Health is undergoing a turnaround with improved fundamentals and operational enhancements. Analysts project annual EPS growth of 10-15% ahead of the August 5 earnings report.